Effect of GDNF-releasing biodegradable microspheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts.
The transplantation of fetal ventral mesencephalic (FVM) cell suspensions into the brain striatal system is an alternative approach for the treatment of Parkinson's disease (PD). However, one objection to this procedure is the relatively poor survival of implanted cells. Attempts have been made to improve the survival of grafted dopaminergic neurons using glial cell line-derived neurotrophic factor (GDNF). Nevertheless, the clinical application of GDNF is limited, due to the difficulties in administering a protein to the brain tissue and due to the ubiquity of its receptor, thus leading to neurological side effects. A strategy to deliver GDNF in the brain based on the intracerebral implantation of biodegradable poly(D,L-lactic acid-co-glycolic acid) sustained release microspheres has been developed. Such microparticles can be easily implanted by sterotaxy in precise and functional areas of the brain without causing damage to the surrounding tissue. Moreover, the release profile of the GDNF-loaded microspheres showed a sustained release over 56 days of biologically active GDNF at clinically relevant doses. The present study shows that the implantation of GDNF-loaded microspheres at a distance to the site of FVM cells in the 6-hydroxydopamine-lesioned rat model of PD improves dopaminergic graft survival and function. Furthermore, the unloaded and the GDNF-loaded microspheres, when they are mixed with FVM cells, may provide a mechanical support and a 3D environment inducing differentiation and increased function of dopaminergic neurons. Taken together, these results show that GDNF microspheres represent an efficient delivery system for cell transplantation studies.
Inserm, U646, Angers, France.
Anne
A
Clavreul
Laurence
L
Sindji
Anne
A
Aubert-Pouëssel
Jean-Pierre
JP
Benoît
Philippe
P
Menei
Claudia N
CN
Montero-Menei
D000818:Animals; D001673:Biodegradation, Environmental; D003342:Corpus Striatum / Q000166:cytology* / Q000196:embryology; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000008:administration & dosage*; D006085:Graft Survival; D007150:Immunohistochemistry; D008636:Mesencephalon / Q000166:cytology* / Q000196:embryology; D008863:Microspheres; D051381:Rats; D017207:Rats, Sprague-Dawley
D051100:Glial Cell Line-Derived Neurotrophic Factor